Autonomize AI Welcomes Michele Paige and Tamara Elias, MD to Growth Advisory Board

Audio By Carbonatix

AUSTIN, Texas--(BUSINESS WIRE)--Oct 2, 2025--

Autonomize AI, the pioneer in Agentic AI orchestration for healthcare and life sciences, today announced the appointment of Michele Paige and Tamara Elias, MD to its Growth Advisory Board. They join a distinguished group of leaders—including Joan Harvey, Pritesh Gandhi, MD, MPH, Anthony Nguyen, MD, MBA, and Sarah Bezerredi—who are shaping Autonomize’s strategy as the company scales its impact across health plans, providers, and pharmacy benefit management organizations.

Michele Paige brings deep expertise in PBM and pharmacy operations, having led product and digital strategy at Elevance Health’s CarelonRx. Her leadership in specialty pharmacy and affordability initiatives will be critical as Autonomize AI accelerates the expansion of its enterprise AI platform and marketplace of pre-built, pre-trained AI Agents into pharmacy-linked workflows.

Tamara Elias, MD is a seasoned physician executive and former private equity partner with nearly a decade of investment experience. She has led operating and partnership initiatives across health plans, life sciences, and technology companies, including senior roles at Microsoft/Nuance, Merck, Aetna, Becton Dickinson, and McKinsey. Her perspective at the intersection of care delivery, pharma, enterprise technology, and capital strategy will help guide Autonomize AI’s next wave of strategic partnerships and growth.

“Welcoming Michele and Tamara to our Growth Advisory Board reflects our commitment to scaling with precision,” said Ganesh Padmanabhan, CEO of Autonomize AI. “Michele’s track record in PBM innovation and Tamara’s rare combination of success in physician leadership, operator experience, and as a private equity partner gives us both strategic and capital perspective. Their expertise will be invaluable as we build the next phase of Autonomize’s growth.”

The company’s Growth Advisory Board, chaired by Joan Harvey, convenes senior leaders from across the healthcare ecosystem to guide Autonomize AI’s expansion strategy and strengthen its position as the agentic AI platform of choice for leading healthcare enterprises.

About Autonomize AI
Autonomize AI uses specialized AI Agents to simplify healthcare’s most complex processes, transforming them into streamlined, AI-native operations. Our solutions reduce administrative bottlenecks across utilization management, care management, contracts, claims, and payments—blending automation with human expertise to deliver faster decisions, lower costs, and better patient experiences.

Trusted by providers, payers, life sciences, and digital health leaders, Autonomize ensures every decision is transparent, defensible, and data-traceable.

For more information, visit www.autonomize.ai.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251002125850/en/

CONTACT: PR Contact

Avenue Z

[email protected]

KEYWORD: TEXAS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: PAYMENTS DATA MANAGEMENT HEALTH TECHNOLOGY HEALTH TECHNOLOGY SOFTWARE ARTIFICIAL INTELLIGENCE

SOURCE: Autonomize AI

Copyright Business Wire 2025.

PUB: 10/02/2025 08:00 AM/DISC: 10/02/2025 07:59 AM

http://www.businesswire.com/news/home/20251002125850/en